The Indianapolis-based Eli Lilly and Co. said the improved facility in Carolina, Puerto Rico, will make orforglipron, Lilly’s highly anticipated GLP-1 pill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback